Candidate drugs (e.g., SGLT-2, incretins, ivabradine, AT1 receptor antagonists) improved the survival of Dahl-sensitive rats, or subjects with HF caused by pressure overload by AAB (TAC). This evidence concerns the gene GCG and hydrops fetalis.